Finance

Lists
BNGO:NASDAQ
BioNano Genomics Inc
USD 1,20
0,00%
(0,00) 1D
USD 1,22
+1,67% (+0,020)
Pre-market
Closed: 21 Aug., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNGO...
Mkt. cap
14,13 m
Avg. vol.
120,26 k
Volume
1,52 k
52-wk high
USD 5,50
52-wk low
USD 1,00
EPS
-USD 3,76
Beta
1,63
Shares outstanding
11,78 m
No. of employees
96
Mkt. cap
14,13 m
Avg. vol.
120,26 k
Volume
1,52 k
52-wk high
USD 5,50
52-wk low
USD 1,00
EPS
-USD 3,76
Beta
1,63
Shares outstanding
11,78 m
No. of employees
96
About BioNano Genomics Inc
CEOErik Holmlin
Employees96
Founded2003
HeadquartersSan Diego, Kalifornië, Verenigde State van Amerika
SectorHealth care
Websitebionano.com
Analyst ratings
Based on 1 analyst giving stock ratings to BNGO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BNGO in the last 3 months
Highest
Current USD 1,20
USD 4,00 (+233,33%)
Average
USD 4,00 (+233,33%)
Lowest
USD 4,00 (+233,33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
USD 4,00
+233,3%
08/11/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
USD 6,00
+400%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
7,37 m
7,95 m
6,69 m
8,17 m
Cost of goods sold
4,00 m
4,55 m
3,44 m
3,86 m
Cost of revenue
4,00 m
4,55 m
3,44 m
3,86 m
Research and development expenses
2,84 m
3,23 m
3,14 m
2,99 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,06 m
8,71 m
8,01 m
8,54 m
Operating expense
11,91 m
11,94 m
11,15 m
11,53 m
Total operating expenses
15,90 m
16,49 m
14,58 m
15,39 m
Operating income
-8,54 m
-8,54 m
-7,90 m
-7,22 m
Other non operating income
-150,00 k
434,00 k
-547,00 k
-274,00 k
EBT including unusual items
-8,49 m
-7,90 m
-8,29 m
-7,42 m
EBT excluding unusual items
-8,49 m
-7,90 m
-8,29 m
-7,42 m
Income tax expense
14,00 k
35,00 k
10,00 k
7,00 k
Effective tax rate
-0,16%
-0,44%
-0,12%
-0,09%
Other operating expenses
-
-
-
-
Net income
-8,50 m
-7,93 m
-8,30 m
-7,42 m
Net profit margin
-115,42%
-99,77%
-124,17%
-90,85%
Earnings per share
-1,59
-0,03
-0,75
-0,60
Interest and investment income
268,00 k
276,00 k
223,00 k
146,00 k
Interest expense
-69,00 k
-72,00 k
-72,00 k
-70,00 k
Net interest expenses
199,00 k
204,00 k
151,00 k
76,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,11 m
-6,35 m
-5,54 m
-4,87 m
Gain or loss from assets sale
-
-
34,00 k
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme